Peter Kaiser

About Peter Kaiser

Peter Kaiser

Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, and Senior Vice President of Product Development at Ohr Pharmaceutical

Actively involved in retinal clinical research, Kaiser has been the study chairman of seven major, multi-center international clinical trials and is a principal investigator in many others. Some of his innovations include the development of new vitreoretinal surgical techniques, pioneering the use of spectral domain OCT for the diagnosis and management of vitreoretinal disease, and being the first physician to use a modified RNA interfering molecule to treat AMD – a true colossus of the retina.